HALEY CART: Open Payments
NPI 1912560541 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 52 payments from 11 companies in 2025. Trend: 2023 $111 · 2024 $133 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $332 |
| Axsome Therapeutics, Inc. | 9 | $136 |
| Novo Nordisk Inc | 5 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $88 |
| Lilly USA, LLC | 3 | $60 |
| Esperion Therapeutics, Inc. | 3 | $48 |
| PFIZER INC. | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: Auvelity, VRAYLAR, QULIPTA, UBRELVY, TRINTELLIX, Wegovy, MOUNJARO, NEXLETOL.
Industry payments across LA — which companies pay providers there.
